Biopharma Daily Stock Updates - 01/25/21

$XBI $157.14 (+3.00%) 📈

COVID:

$MRNA (+12.20%) - Moderna COVID-19 Vaccine Retains Neutralizing Activity Against Emerging Variants First Identified in the U.K. and the Republic of South Africa

$EBS (-0.75%) & HGEN (-2.04%) - Humanigen and Emergent BioSolutions Announce Contract Development and Manufacturing Agreement for Phase 3 COVID-19 Therapeutic Candidate Lenzilumab™

$DVAX (+25.48%) - Medigen Vaccine Biologics COVID-19 Vaccine Adjuvanted with Dynavax's CpG 1018 Announces First Participant Dosed in Phase 2 Clinical Trial in Taiwan

PIPELINE:

$AUPH (+26.04%) - Approval

$EIGR (-0.93%) - Eiger BioPharmaceuticals Announces U.S. Commercial Availability of Zokinvy™ (lonafarnib), the First and Only Treatment Approved for Progeria and Processing-Deficient Progeroid Laminopathies

$DRRX (+6.22%) - DURECT Corporation Announces First Patient Dosed in Phase 2b AHFIRM Study of DUR-928 in Severe Alcohol-Associated Hepatitis

$ALBO (+3.76%) - Albireo Announces U.S. FDA Acceptance of New Drug Application for Odevixibat

$ABEO (+9.91%) - Abeona Therapeutics Announces Successful Type B Meeting with FDA for Pivotal Phase 3 VIITAL™ Study of EB-101 in Recessive Dystrophic Epidermolysis Bullosa (RDEB)

DTIL (+1.28%) - Precision BioSciences Receives Notice of Allowance for U.S. Patent Application Covering PBCAR19B, a Stealth Cell, CD19 Allogeneic CAR T Candidate for Non-Hodgkin Lymphoma

$AZN (+1.43%) - Calquence approved in Japan for the treatment of relapsed or refractory chronic lymphocytic leukaemia

$AZN (+1.43%) - Calquence met primary efficacy endpoint in head-to-head trial against ibrutinib in chronic lymphocytic leukaemia

$CYCN (-0.90%) - Cyclerion Therapeutics Announces Clinical and Scientific Advisory Boards

FINANCIAL:

$BHVN (+8.52%) - BIOHAVEN ANNOUNCES PRELIMINARY 4Q2020 NET PRODUCT REVENUE FOR NURTEC® ODT

$GNFT (-4.26%) - GENFIT: Sweeping approval of OCEANEs buyback and amendments of terms

$ONCS (-0.69%) - OncoSec Medical Closes $42.0 Million Public Offering of Common Stock